Associations of metabolic syndrome in SLE.

ABSTRACT:

Objectives

To characterise the prevalence and associations of metabolic syndrome (MetS) in a multiethnic cohort of patients with SLE.

Methods

Using a standardised protocol, baseline demographics, per visit disease activity (Systemic Lupus Erythematosus Disease Activity Index-2K) and treatment data, and annual recording of organ damage accrual (Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC-ACR) Damage Index) were captured on patients with SLE from a single tertiary centre. The presence of MetS, defined using modified updated joint consensus criteria, was assessed at the final visit from patient records. Serum concentrations of adipocytokines were measured by Quantibody.

Results

116 patients, with median (Q1, Q3) age at enrol

SUBMITTER: Apostolopoulos D 

PROVIDER: S-EPMC7668361 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature